Update on the Use of Conjugate Pneumococcal Vaccines in Childhood: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI)†
- PMID: 31697280
- PMCID: PMC6802447
- DOI: 10.14745/ccdr.v36i00a12
Update on the Use of Conjugate Pneumococcal Vaccines in Childhood: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI)†
Figures
References
-
- National Advisory Committee on Immunization. An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Statement on recommended use of pneumococcal conjugate vaccine. Can Commun Dis Rep 2002. Jan;28 ACS-2:1–32. - PubMed
-
- National Advisory Committee on Immunization. Statement on the recommended use of pneumococcal conjugate vaccine [Addendum] Can Commun Dis Rep 2003;29 ACS-8:14–6. - PubMed
-
- National Advisory Committee on Immunization (NACI). Update on the recommendations for the routine use of pneumococcal conjugate vaccine for infants. An Advisory Committee Statement (ACS). Can Commun Dis Rep 2006. May;32 ACS-4:1–6.
-
- National Advisory Committee on Immunization (NACI). Update on paediatric invasive pneumococcal disease and recommended use of conjugate pneumococcal vaccines. Can Commun Dis Rep 2010. Mar;36 ACS-2:1–6. - PubMed
-
- Bettinger JA, Scheifele DW, Kellner JD, Halperin SA, Vaudry W, Law B et al. ; Canadian Immunization Monitoring Program, Active (IMPACT). The effect of routine vaccination on invasive pneumococcal infections in Canadian children, Immunization Monitoring Program, Active 2000-2007. Vaccine 2010. Feb;28(9):2130–6. 10.1016/j.vaccine.2009.12.026 - DOI - PubMed
